Grasustek 6 mg, solution injectable en seringue préremplie

7680681660019 CH-68166 Lösung
Grasustek 6 mg, solution injectable en seringue préremplie
Grasustek 6 mg, solution injectable en seringue préremplie
Grasustek 6 mg, solution injectable en seringue préremplie
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
09/11/2021
Summary of Product Characteristics
Français
09/11/2021
Summary of Product Characteristics
Italien
09/11/2021
Patient information leaflet
Allemand
08/11/2021
Patient information leaflet
Français
08/11/2021
Patient information leaflet
Italien
08/11/2021

Detailed composition

Substance Quantity Type Category
(N/A)
6.0 MG Substance Wirkstoff (Principe actif)
(N/A)
30.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.02 MG Substance HBESI

Reimbursement information

Public price
CHF 1105.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2021

Authorization holder

IQONE HEALTHCARE SWITZERLAND

1290 Versoix

Authorization information

Swissmedic authorization number
68166
Drug name
Grasustek, solution injectable en seringue préremplie
Galenic form
INLFS
ATC Code
L03AA13
Authorization status
Z
Dispensing category
A
First authorization
07/04/2021
Authorization expiration date
06/04/2026
IT Number
06.07.3.
Domain
Human medicine
Field of application
Neutropenie

Package details

Description (FR)
GRASUSTEK sol inj 6 mg/0.6ml ser préremp 0.6 ml
Description (DE)
GRASUSTEK Inj Lös 6 mg/0.6ml Fertigspr 0.6 ml
Market launch
07/04/2021
Narcotic (BTM)
No